跳转至内容
Merck
CN

912182

Sigma-Aldrich

Enantioprobe (S,S)-7

≥95%

别名:

N-((1S,2S)-2-(Benzyloxy)cyclopentyl)-3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propanamide, Fully functionalized enantioprobe, Ligandability probe

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C20H25N3O2
分子量:
339.43
MDL编号:
UNSPSC代码:
12352101
NACRES:
NA.22

质量水平

方案

≥95%

表单

powder

储存温度

−20°C

SMILES字符串

N([C@@H]2[C@H](CCC2)OCc3ccccc3)C(=O)CCC1(N=N1)CCC#C

InChI

1S/C20H25N3O2/c1-2-3-13-20(22-23-20)14-12-19(24)21-17-10-7-11-18(17)25-15-16-8-5-4-6-9-16/h1,4-6,8-9,17-18H,3,7,10-15H2,(H,21,24)/t17-,18-/m0/s1

InChI key

JWDFLBJRNHEKSI-ROUUACIJSA-N

应用

Enantioprobe (S,S)-7 is one of 16 fully functionalized, enantiomeric fragment probes developed in the Cravatt lab. Combining fragment-based ligand discovery (FBLD) with chemical proteomics, the enantioprobe library assesses ligandability across proteomes. Each enantioprobe contains a structurally variable fragment for interaction with proteins, photoactivatable diazirine for UV-induced covalent protein labeling, and bioorthogonal alkyne handle for detection, enrichment, and identification. Of the eight enantiomeric pairs, each differs by one stereocenter, and comparing stereoselective fragment-protein interactions betweenthe pairs simplifies validation of authentic protein-binding events. Enantioprobe (S,S)-7′s paired fragment is available as Enantioprobe (R,R)-7 (cat# 913413).

Together, the 16 enantioprobes support ligandability studies in living cells, a significant method for development of chemical probes and lead discovery efforts to find binders for traditionally ″″undruggable″″ protein targets. This strategy is also compatible with multiplexing for higher throughput.
Supporting reagents:

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Yujia Wang et al.
Nature chemistry, 11(12), 1113-1123 (2019-10-30)
A fundamental challenge in chemical biology and medicine is to understand and expand the fraction of the human proteome that can be targeted by small molecules. We recently described a strategy that integrates fragment-based ligand discovery with chemical proteomics to

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门